Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 12, 2013

Bayer, Gentium, GlaxoSmithKline, Paladin, PsiOxus, Shield Therapeutics, The Medicines Co.

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I Gentium DF test successful . . . read more Phase II PsiOxus gets good results against cachexia . . . read more Phase III GSK plaque-buster misses endpoint . . . read more Shield files to begin CKD trial . . . read more Filings Bayer receives Eylea approval in Canada . . . read more Paladin review date extended . . . read more TMC’s ABSSSI NDA gets QIDP . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters